- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 12206
Historique des publications depuis 10 ans
|
474
|
639
|
846
|
931
|
1065
|
1219
|
1118
|
1212
|
1210
|
142
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1133 |
667 |
| Iovance Biotherapeutics, Inc. | 359 |
267 |
| The Regents of the University of California | 20378 |
247 |
| The Trustees of the University of Pennsylvania | 4384 |
219 |
| Board of Regents, The University of Texas System | 6010 |
153 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2945 |
152 |
| Cellectis | 406 |
132 |
| Memorial Sloan-Kettering Cancer Center | 1991 |
127 |
| Juno Therapeutics, Inc. | 470 |
116 |
| Baylor College of Medicine | 986 |
112 |
| The Board of Trustees of the Leland Stanford Junior University | 6587 |
103 |
| Novartis AG | 10463 |
100 |
| Immunitybio, Inc. | 487 |
99 |
| City of Hope | 1007 |
92 |
| Autolus Limited | 263 |
87 |
| Kite Pharma, Inc. | 427 |
87 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1000 |
82 |
| Regents of the University of Minnesota | 2764 |
77 |
| FATE Therapeutics, Inc. | 219 |
75 |
| Kyoto University | 2877 |
73 |
| Autres propriétaires | 9139 |